1. A multi‐centre phase I trial of the PARP inhibitor olaparib in patients with relapsed chronic lymphocytic leukaemia, T‐prolymphocytic leukaemia or mantle cell lymphoma. (23rd June 2017) Authors: Pratt, Guy; Yap, Christina; Oldreive, Ceri; Slade, Daniel; Bishop, Rebecca; Griffiths, Mike; Dyer, Martin J. S.; Fegan, Chris; Oscier, David; Pettitt, Andrew; Matutes, Estella; Devereux, Stephen; Allsup, David; Bloor, Adrian; Hillmen, Peter; Follows, George; Rule, Simon; Moss, Paul; Stankovic, Ta... Journal: British journal of haematology Issue: Volume 182:Number 3(2018) Page Start: 429 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Lck is a relevant target in chronic lymphocytic leukaemia cells whose expression variance is unrelated to disease outcome. Issue 1 (December 2017) Authors: Till, Kathleen; Allen, John; Talab, Fatima; Lin, Ke; Allsup, David; Cawkwell, Lynn; Bentley, Alison; Ringshausen, Ingo; Duckworth, Andrew; Pettitt, Andrew; Kalakonda, Nagesh; Slupsky, Joseph Journal: Scientific reports Issue: Volume 7:Issue 1(2017) Page Start: 1 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. 0142 Training in safe administration of intrathecal chemotherapy – is in situ simulation the answer?: A pilot study. (2nd November 2015) Authors: Prakash, Anoop; Farooq, Omer; Durairaj, Senthilkumar; Allsup, David; Purva, Makani Journal: BMJ simulation & technology enhanced learning Issue: Volume 1(2015)Supplement 2 Page Start: A56 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. P10 Biomarker Driven Antifungal Stewardship in Acute Leukaemia (BioDriveAFS)—a multicentre randomized controlled trial to assess clinical and cost effectiveness. (31st May 2022) Authors: Taynton, Thomas; Parker, Adwoa; Flett, Lydia; Laycock, Joanne; Newman, Joanne; Fairhurst, Caroline; Hope, William; Lillie, Patrick; Tharmanathan, Puvanendran; Corbacho, Belén; Sheard, Laura; Hilton, Andrea; Gandhi, Shreyans; Gray, Hannah; Guise, Tracey; Sneddon, Jacqui; Torgerson, David; Allsup, ... Journal: JAC-antimicrobial resistance Issue: Volume 4(2022)Supplement 2 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. The use of ofatumumab in the treatment of B-cell malignancies. (December 2017) Authors: Soe, Zar Ni; Allsup, David Journal: Future oncology Issue: Volume 13:Number 29(2017) Page Start: 2611 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PRO: Biomarker surveillance for invasive fungal infections without antifungal prophylaxis could safely reduce antifungal use in acute leukaemia. Issue 4 (22nd July 2022) Authors: Taynton, Thomas; Barlow, Gavin; Allsup, David Journal: JAC-antimicrobial resistance Issue: Volume 4:Issue 4(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Immunomodulation mediated by polyclonal IgG replacement in patients with chronic lymphocytic leukemia may be important in infection prevention. Issue 4 (2nd May 2022) Authors: Khan, Sujoy; Molica, Stefano; Allsup, David Journal: Hematological oncology Issue: Volume 40:Issue 4(2022) Page Start: 528 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Next‐generation sequencing for the diagnosis of MYH9‐RD: Predicting pathogenic variants. Issue 1 (15th October 2019) Authors: Bury, Loredana; Megy, Karyn; Stephens, Jonathan C.; Grassi, Luigi; Greene, Daniel; Gleadall, Nick; Althaus, Karina; Allsup, David; Bariana, Tadbir K.; Bonduel, Mariana; Butta, Nora V.; Collins, Peter; Curry, Nicola; Deevi, Sri V. V.; Downes, Kate; Duarte, Daniel; Elliott, Kim; Falcinelli, Emanuel... Journal: Human mutation Issue: Volume 41:Issue 1(2020) Page Start: 277 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. A comprehensive targeted next‐generation sequencing panel for genetic diagnosis of patients with suspected inherited thrombocytopenia. Issue 4 (8th October 2018) Authors: Johnson, Ben; Doak, Rachel; Allsup, David; Astwood, Emma; Evans, Gillian; Grimley, Charlotte; James, Beki; Myers, Bethan; Stokley, Simone; Thachil, Jecko; Wilde, Jonathan; Williams, Mike; Makris, Mike; Lowe, Gillian C.; Wallis, Yvonne; Daly, Martina E.; Morgan, Neil V. Journal: Research and practice in thrombosis and haemostasis Issue: Volume 2:Issue 4(2018) Page Start: 640 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. Current and emerging investigational venetoclax-based therapies in chronic lymphocytic leukemia. (3rd June 2021) Authors: Molica, Stefano; Allsup, David; Gianfelici, Valentina; Levato, Luciano; Aiello, Vincenzo; Bailey, James; Polliack, Aaron Journal: Expert opinion on investigational drugs Issue: Volume 30:Number 6(2021) Page Start: 621 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗